Top compounds associated with response to RPE


Feature Type Standardized
Nominal ANOVA
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.19 1e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.21 0.0004
Download CSV